Seiji Ito
About Seiji Ito
Seiji Ito is the Director, Oncology Executive Medical Science Liaison at Bristol-Myers Squibb, Japan Medical & Development, with over 17 years of experience in the company.
Company
Seiji Ito is associated with Bristol-Myers Squibb, where he currently holds the position of Director, Oncology Executive Medical Science Liaison. The company is located at 5-1, Nishi-Shinjuku 6-chome, Shinjuku-ku, Tokyo 163-1328, Japan. Bristol-Myers Squibb is a notable entity in the pharmaceutical industry, with a strong focus on developing medications for oncology and other therapeutic areas.
Title
Seiji Ito serves as the Director, Oncology Executive Medical Science Liaison, Japan Medical & Development at Bristol-Myers Squibb. He is also known to have held the role of Director, Oncology Marketing in New York, United States.
Education and Expertise
Seiji Ito studied at Keio University from 1977 to 1982. His expertise covers extensive experience in the pharmaceutical industry, specifically in oncology. He has transitioned from marketing roles to medical science liaison roles, showcasing a diverse skill set in both areas.
Background
Seiji Ito has been with Bristol-Myers Squibb for over 17 years. He began his journey with the company in 2006 as a Senior Product Manager in New York and served in that capacity for 7 years. Later, he transitioned to his current role, where he has been serving for over 7 years, focusing on the Japanese market and oncology.
Experience in Oncology
Seiji Ito has extensive experience in oncology, particularly within the Japanese market. He has held the role of Director, Oncology Executive Medical Science Liaison for over 7 years, and this tenure reflects his deep expertise and commitment to advancing oncology treatments and solutions at Bristol-Myers Squibb.